-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

Benzinga·03/30/2026 14:16:37
Listen to the news
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $2.75 to $1.